[
  {
    "ts": null,
    "headline": "Bank earnings, United earnings, PPI, Fed talk: What to Watch",
    "summary": "Market Domination Overtime with Josh Lipton outlines the top stories for investors to watch on Wednesday, July 16. A fresh slate of earnings reports is set to be published. In the morning, Bank of America (BAC), Morgan Stanley (MS), Goldman Sachs (GS), ASML (ASML), and Johnson & Johnson (JNJ) will release earnings. In the afternoon, United Airlines (UAL) will report earnings. Producer Price Index (PPI) data for June will be out in the morning, with economists expecting a slight uptick on a month-over-month basis. More commentary from Federal Reserve officials is coming, with remarks from Fed governor Michael Barr and New York Fed President John Williams. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
    "url": "https://finnhub.io/api/news?id=33bf8fdeb69f09936c4b1cd3725c0bda46611005f6fdfa56bbe4050fada35ec6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752620400,
      "headline": "Bank earnings, United earnings, PPI, Fed talk: What to Watch",
      "id": 135957768,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Market Domination Overtime with Josh Lipton outlines the top stories for investors to watch on Wednesday, July 16. A fresh slate of earnings reports is set to be published. In the morning, Bank of America (BAC), Morgan Stanley (MS), Goldman Sachs (GS), ASML (ASML), and Johnson & Johnson (JNJ) will release earnings. In the afternoon, United Airlines (UAL) will report earnings. Producer Price Index (PPI) data for June will be out in the morning, with economists expecting a slight uptick on a month-over-month basis. More commentary from Federal Reserve officials is coming, with remarks from Fed governor Michael Barr and New York Fed President John Williams. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
      "url": "https://finnhub.io/api/news?id=33bf8fdeb69f09936c4b1cd3725c0bda46611005f6fdfa56bbe4050fada35ec6"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow, S&P 500, Nasdaq futures wobble as Fed rate cut bets wane after inflation pickup",
    "summary": "Wall Street braced for another inflation checkup after Tuesday's consumer price reading spurred traders to pare bets on Fed rate cuts in the coming months.",
    "url": "https://finnhub.io/api/news?id=0704df8d61013262b3e28659128b53a78a0da8d68cd3d49ac5277bbd867beb9e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752619844,
      "headline": "Stock market today: Dow, S&P 500, Nasdaq futures wobble as Fed rate cut bets wane after inflation pickup",
      "id": 135957769,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Wall Street braced for another inflation checkup after Tuesday's consumer price reading spurred traders to pare bets on Fed rate cuts in the coming months.",
      "url": "https://finnhub.io/api/news?id=0704df8d61013262b3e28659128b53a78a0da8d68cd3d49ac5277bbd867beb9e"
    }
  },
  {
    "ts": null,
    "headline": "Netflix, Goldman Sachs, J&J: Earnings to Watch This Week",
    "summary": "Earnings season takes off this week led by U.S. banks. JPMorgan Chase, Goldman Sachs and others. Big non-financial companies including Johnson & Johnson, Netflix and PepsiCo are also on the way. Here are the highlights of who is reporting, and the expected approximate release times.",
    "url": "https://finnhub.io/api/news?id=c64ebcadd0c51d49f4cdf095934d19683e1b471ea6ed27274e0547beb02d24c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752569101,
      "headline": "Netflix, Goldman Sachs, J&J: Earnings to Watch This Week",
      "id": 135942046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Earnings season takes off this week led by U.S. banks. JPMorgan Chase, Goldman Sachs and others. Big non-financial companies including Johnson & Johnson, Netflix and PepsiCo are also on the way. Here are the highlights of who is reporting, and the expected approximate release times.",
      "url": "https://finnhub.io/api/news?id=c64ebcadd0c51d49f4cdf095934d19683e1b471ea6ed27274e0547beb02d24c3"
    }
  },
  {
    "ts": null,
    "headline": "3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS",
    "summary": "The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.",
    "url": "https://finnhub.io/api/news?id=1e2553b275d78872994ece29db54df16a2700ce7fc1de3a7ed0c766d33c03b3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752612900,
      "headline": "3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS",
      "id": 135957771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.",
      "url": "https://finnhub.io/api/news?id=1e2553b275d78872994ece29db54df16a2700ce7fc1de3a7ed0c766d33c03b3d"
    }
  },
  {
    "ts": null,
    "headline": "XPH: Healthcare Dashboard For July",
    "summary": "XPH ETF offers equal-weighted exposure to pharmaceutical companies, with lackluster results for a decade. Click here to find out why XPH stock is a Hold.",
    "url": "https://finnhub.io/api/news?id=f06d8fa42a12451bc189fb589853168778c65a1452470f7473adbf64804e67f9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752599588,
      "headline": "XPH: Healthcare Dashboard For July",
      "id": 135956660,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1557045133/image_1557045133.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "XPH ETF offers equal-weighted exposure to pharmaceutical companies, with lackluster results for a decade. Click here to find out why XPH stock is a Hold.",
      "url": "https://finnhub.io/api/news?id=f06d8fa42a12451bc189fb589853168778c65a1452470f7473adbf64804e67f9"
    }
  },
  {
    "ts": null,
    "headline": "Wolfe Research Affirms Outperform Rating on Johnson & Johnson (JNJ) on Improving Fundamentals",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research reiterated an ‘Outperform’ rating on the stock and a $175 price target. The bullish stance underscores the company’s strong performance year to date amid soaring regulatory concerns. The stock is up by more than 8% […]",
    "url": "https://finnhub.io/api/news?id=480473e2b2083f8aecaa5f7485bc7d05e8424c72b2459de1a43e4f9bf38732b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752585031,
      "headline": "Wolfe Research Affirms Outperform Rating on Johnson & Johnson (JNJ) on Improving Fundamentals",
      "id": 135957772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research reiterated an ‘Outperform’ rating on the stock and a $175 price target. The bullish stance underscores the company’s strong performance year to date amid soaring regulatory concerns. The stock is up by more than 8% […]",
      "url": "https://finnhub.io/api/news?id=480473e2b2083f8aecaa5f7485bc7d05e8424c72b2459de1a43e4f9bf38732b4"
    }
  },
  {
    "ts": null,
    "headline": "Inflation Data and Bank Earnings Kick Off a Crucial Test for Markets",
    "summary": "The big US banks bested Q1 earnings expectations, and many observers expect big boosts to their Q2 trading desk revenues.",
    "url": "https://finnhub.io/api/news?id=c8af44f4dbc1b15db4806df20c33ad9b94794af6887b1c92dc19f7c596862072",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752575400,
      "headline": "Inflation Data and Bank Earnings Kick Off a Crucial Test for Markets",
      "id": 135957773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The big US banks bested Q1 earnings expectations, and many observers expect big boosts to their Q2 trading desk revenues.",
      "url": "https://finnhub.io/api/news?id=c8af44f4dbc1b15db4806df20c33ad9b94794af6887b1c92dc19f7c596862072"
    }
  },
  {
    "ts": null,
    "headline": "Harding Loevner Global Equity Q2 2025 Report",
    "summary": "The Global Equity composite rose 10.3% gross of fees in the second quarter, lagging the 11.7% gain in the MSCI ACWI Index.",
    "url": "https://finnhub.io/api/news?id=8ec65fb5791a8926881b2ee37698c3f7289d7fd8997db8809c0e93fef327274b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752573600,
      "headline": "Harding Loevner Global Equity Q2 2025 Report",
      "id": 135945766,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2067714497/image_2067714497.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The Global Equity composite rose 10.3% gross of fees in the second quarter, lagging the 11.7% gain in the MSCI ACWI Index.",
      "url": "https://finnhub.io/api/news?id=8ec65fb5791a8926881b2ee37698c3f7289d7fd8997db8809c0e93fef327274b"
    }
  },
  {
    "ts": null,
    "headline": "Bank Earnings, Inflation Data, Retail Sales: What to Watch This Week",
    "summary": "This week, earnings season gets into full swing with results from big banks and others, while the Labor Department releases June inflation data. Wall Street is watching for updates on President Trump’s tariff policies, though investors have so far mostly shrugged off concerns when the administration detailed levies for dozens of countries.",
    "url": "https://finnhub.io/api/news?id=d4c49d0fc539e471122f34956485efc880dc3c3b1732fca694c2d2c1958f1f0a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752567442,
      "headline": "Bank Earnings, Inflation Data, Retail Sales: What to Watch This Week",
      "id": 135940123,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "This week, earnings season gets into full swing with results from big banks and others, while the Labor Department releases June inflation data. Wall Street is watching for updates on President Trump’s tariff policies, though investors have so far mostly shrugged off concerns when the administration detailed levies for dozens of countries.",
      "url": "https://finnhub.io/api/news?id=d4c49d0fc539e471122f34956485efc880dc3c3b1732fca694c2d2c1958f1f0a"
    }
  },
  {
    "ts": null,
    "headline": "Kenvue: New CEO, Watch The Dividend (Rating Downgrade)",
    "summary": "Kenvue CEO steps down amid poor performance and ongoing strategic review.",
    "url": "https://finnhub.io/api/news?id=dbb4ef026d6ca69619f32724ec46f5a7a42106b092dba50f0867cac29a2d5dc9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752564600,
      "headline": "Kenvue: New CEO, Watch The Dividend (Rating Downgrade)",
      "id": 135941966,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/688022852/image_688022852.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Kenvue CEO steps down amid poor performance and ongoing strategic review.",
      "url": "https://finnhub.io/api/news?id=dbb4ef026d6ca69619f32724ec46f5a7a42106b092dba50f0867cac29a2d5dc9"
    }
  },
  {
    "ts": null,
    "headline": "Mar Vista U.S. Quality Premier Strategy Q2 2025 Commentary",
    "summary": "Mar Vistaâs U.S. Quality Premier strategy returned +14.29% net-of-fees in the second quarter of 2025. Read more here.",
    "url": "https://finnhub.io/api/news?id=ac0bd501765f331bf540224a62ce4ef94151cca218cbfbc89b5c0bd5ba469fef",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752564600,
      "headline": "Mar Vista U.S. Quality Premier Strategy Q2 2025 Commentary",
      "id": 135941963,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1751834130/image_1751834130.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Mar Vistaâs U.S. Quality Premier strategy returned +14.29% net-of-fees in the second quarter of 2025. Read more here.",
      "url": "https://finnhub.io/api/news?id=ac0bd501765f331bf540224a62ce4ef94151cca218cbfbc89b5c0bd5ba469fef"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy Johnson & Johnson Stock Before July 16th?",
    "summary": "Historically, Johnson & Johnson has been a fairly stable stock to own.  Johnson & Johnson (NYSE: JNJ) has been a leading healthcare company in the world for decades, and it's one of the most valuable as well, with a market cap of around $380 billion.  Known for its long-term stability and dividend growth, it's a blue chip stock that is primarily suitable for risk-averse investors who want to collect a reliable payout.",
    "url": "https://finnhub.io/api/news?id=1f8708ded5369568d8e3d03f26a6f47dcd76a23d615811d510aa39274785d8a3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752562800,
      "headline": "Should You Buy Johnson & Johnson Stock Before July 16th?",
      "id": 135936840,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Historically, Johnson & Johnson has been a fairly stable stock to own.  Johnson & Johnson (NYSE: JNJ) has been a leading healthcare company in the world for decades, and it's one of the most valuable as well, with a market cap of around $380 billion.  Known for its long-term stability and dividend growth, it's a blue chip stock that is primarily suitable for risk-averse investors who want to collect a reliable payout.",
      "url": "https://finnhub.io/api/news?id=1f8708ded5369568d8e3d03f26a6f47dcd76a23d615811d510aa39274785d8a3"
    }
  },
  {
    "ts": null,
    "headline": "J&J: will present its neurovascular innovations at SNIS conference",
    "summary": "Johnson & Johnson MedTech announces that it will take advantage of the SNIS 2025 conference, held in Nashville from 14 to 18 July, to highlight its advances in neurointervention, celebrating 25 years...",
    "url": "https://finnhub.io/api/news?id=3489e4b5d19a2b6637f6f87a61ea71bb41a746a6418e8d7626ad42184298d684",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752557309,
      "headline": "J&J: will present its neurovascular innovations at SNIS conference",
      "id": 135939222,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson MedTech announces that it will take advantage of the SNIS 2025 conference, held in Nashville from 14 to 18 July, to highlight its advances in neurointervention, celebrating 25 years...",
      "url": "https://finnhub.io/api/news?id=3489e4b5d19a2b6637f6f87a61ea71bb41a746a6418e8d7626ad42184298d684"
    }
  }
]